Structures by: Natale N. R.
Total: 18
Ethyl 5-methyl-3-[11-(pyridin-2-yl)-6,11-dihydro-6,11-epoxydibenzo[<i>b</i>,<i>e</i>]oxepin-6-yl]isoxazole-4-carboxylate
C26H20N2O5
Acta Crystallographica Section E (2020) 76, 12 1818-1822
a=19.0586(7)Å b=13.9627(5)Å c=8.1459(3)Å
α=90° β=101.7800(11)° γ=90°
2,2'-[(2-Nitrophenyl)methylene]bis(3-hydroxy-5,5-dimethylcyclohex-2-enone)
C23H27NO6
Acta Crystallographica Section E (2020) 76, 2 125-131
a=8.7024(3)Å b=9.8709(4)Å c=13.1621(5)Å
α=90.3822(19)° β=108.9608(18)° γ=97.3571(18)°
Ethyl 4-(anthracen-9-yl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate
C29H29NO3
Acta Crystallographica Section E (2020) 76, 2 125-131
a=11.6527(3)Å b=18.1986(4)Å c=12.3435(3)Å
α=90° β=114.8758(12)° γ=90°
Ethyl 4-(4-hydroxy-3,5-dimethoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate
C23H29NO6
Acta Crystallographica Section E (2020) 76, 2 125-131
a=10.8854(4)Å b=25.2446(10)Å c=15.3665(6)Å
α=90° β=100.7606(19)° γ=90°
Ethyl 4-[4-(dimethylamino)phenyl]-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate
C23H30N2O3
Acta Crystallographica Section E (2018) 74, 10 1417-1420
a=9.6834(3)Å b=18.2390(5)Å c=12.2073(3)Å
α=90° β=105.4464(14)° γ=90°
Substituted isoxazole carboxylic acid ethyl ester
C24H28N2O7
Acta Crystallographica Section E (2004) 60, 12 o2255-o2257
a=13.302(3)Å b=11.707(2)Å c=14.412(3)Å
α=90.00° β=91.76(3)° γ=90.00°
Ethyl 3-(10-chloroanthracenyl)-5-(1-phenyl-2-hydroxyethenyl)isoxazole-4-carboxylate
C28H20ClNO4
Acta Crystallographica Section E (2006) 62, 2 o854-o856
a=10.6621(12)Å b=15.5874(17)Å c=13.2180(15)Å
α=90.00° β=92.069(2)° γ=90.00°
Ethyl 3-(9-anthryl)-5-methyl-4-isoxazolecarboxylate
C21H17NO3
Acta Crystallographica Section C (1996) 52, 10 2513-2515
a=10.27430(10)Å b=9.6211(2)Å c=17.3827(4)Å
α=90.00° β=94.9500(10)° γ=90.00°
Ethyl 5-methyl-4-(2-bromomethyl-5,5-dimethyl-1,3-dioxan-2-yl)isoxazole-3-carboxylate
C14H20BrNO5
Acta Crystallographica Section E (2007) 63, 5 o2258-o2260
a=8.9698(5)Å b=9.3913(5)Å c=11.1474(6)Å
α=68.299(3)° β=72.618(3)° γ=68.573(3)°
Ethyl 4-(4-bromophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate
C21H24BrNO3
Acta Crystallographica Section C (2014) 70, 8
a=18.0371(4)Å b=15.4309(3)Å c=14.2604(3)Å
α=90° β=90° γ=90°
Ethyl 4-(2-bromophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate
C21H24BrNO3
Acta Crystallographica Section C (2014) 70, 8
a=14.5012(18)Å b=18.299(2)Å c=15.1952(19)Å
α=90° β=107.5262(15)° γ=90°
Ethyl 4-(3-bromophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate
C21H24BrNO3
Acta Crystallographica Section C (2014) 70, 8
a=17.0813(5)Å b=15.4877(5)Å c=14.2544(5)Å
α=90° β=90° γ=90°
C14H21NO5
C14H21NO5
Acta Crystallographica Section C (2000) 56, 9 1146-1147
a=8.5710(8)Å b=9.5382(9)Å c=10.3449(9)Å
α=105.7991(10)° β=94.1123(11)° γ=112.6952(13)°
Ethyl 4-{1-[(2,4-dinitrophenyl)hydrazono]ethyl}- 5-(2-naphthylmethoxymethyl)isoxazole-3-carboxylate
C26H23N5O8
Acta Crystallographica Section E (2009) 65, 1 o144-o145
a=7.0839(6)Å b=12.1760(10)Å c=14.184(2)Å
α=90.5810(10)° β=95.925(2)° γ=99.251(2)°
3-(1,3-Diphenylpropan-2-yl)-4-methyl-6-phenylisoxazolo[3,4-<i>d</i>]pyridazin-7(6<i>H</i>)-one
C27H23N3O2
Acta Crystallographica Section E (2013) 69, 11 o1680-o1681
a=7.5163(4)Å b=9.6774(5)Å c=15.9053(8)Å
α=86.7980(10)° β=83.5120(10)° γ=69.3850(10)°
Diethyl 4-(biphenyl-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
C25H27NO4
Acta Crystallographica Section E (2014) 70, 7 o791-o792
a=7.3431(3)Å b=10.6075(4)Å c=13.8449(6)Å
α=85.762(3)° β=88.124(3)° γ=73.530(2)°
Ethyl 3-(10-bromoanthracen-9-yl)-5-methyl-1,2-oxazole-4-carboxylate
C21H16BrNO3
Acta Crystallographica Section E (2013) 69, 12 o1804-o1805
a=8.84370(10)Å b=16.7099(2)Å c=11.7157(2)Å
α=90° β=92.4190(10)° γ=90°
Ethyl 3-(9-chloro-10-oxo-9,10-dihydroanthracen-9-yl)-5-methylisoxazole-4-\ carboxylate
C21H16Cl1N1O4
Acta Crystallographica Section E (2014) 70, 3 o315-o316
a=10.0121(3)Å b=12.6146(4)Å c=14.9503(4)Å
α=77.9547(14)° β=73.4361(13)° γ=89.1187(13)°